Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer
Journal of Clinical Oncology - United States
doi 10.1200/jco.2014.55.7504
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2015
Authors
Publisher
American Society of Clinical Oncology (ASCO)